MAPT and Alzheimer disease: Furthermore, some AD patients, despite negative Aβ PET results, present with characteristic tau propagation patterns (Thijssen et al., 2021), implying that Aβ deposition may serve as an initiating factor rather than the sole driver of disease progression (Chun et al., 2020).